4 papers analyzed
These studies suggest that treatment retention for methamphetamine has decreased in the United States due to the increased methamphetamine-related treatment admissions linked to the opioid crisis and the reduced likelihood of retention in buprenorphine treatment for opioid use disorders.
Methamphetamine use has been on the rise in the United States, posing significant challenges for treatment retention among individuals with substance use disorders. This synthesis aims to explore the reasons behind the decreased retention rates in methamphetamine treatment programs.
Concurrent Substance Use:
Demographic and Socioeconomic Factors:
Treatment Program Efficacy:
The decrease in treatment retention for methamphetamine in the United States can be attributed to the concurrent use of other substances, particularly opioids, and the demographic and socioeconomic challenges faced by individuals. While certain treatment programs show promise, the multifaceted nature of methamphetamine dependence necessitates comprehensive and tailored approaches to improve retention rates.
Is Pills safe?
how long would it take to create an atmosphere on mars
are alligators dinosaurs
what are the most relevant publications on "supply chain resilience"?
How do we analyze and interpret chemical data using computational methods?
virtual reality in education